title: Osteoporosis in children and adolescent girls: case report of idiopathic juvenile osteoporosis and review of the literature.
abstract: The diagnosis and treatment of osteoporosis is an important aspect of gynecologic training and practice. Idiopathic juvenile osteoporosis (IJO) is a rare disease of children and adolescents that resolves after the onset of puberty. A case report is presented and current methods of diagnosis and treatment of IJO are discussed as well as the differential diagnosis. A MEDLINE search was performed of the following terms: idiopathic juvenile osteoporosis, pediatric osteoporosis, adolescent osteoporosis, bisphosphonates pediatric adolescent, and pregnancy osteoporosis, and references from bibliographies of selected papers were used as well. All papers in English, French, and German are considered in this review. There were 114 papers selected as relevant to the topic. Data relevant to the diagnosis, pathogenesis, methods of imaging, laboratory evaluation, differential diagnosis, and treatment of IJO are presented. IJO is a diagnosis of exclusion in the pediatric and adolescent patient with osteoporosis. Although bone density gradually improves after the onset of puberty, treatment of currently affected children and adolescents involves activity restriction, calcium, vitamin D, and bisphosphonate therapy. Future reproductive concerns are discussed and areas requiring additional study are reviewed.
  
  
  BACKGROUND
  Obstetricians & Gynecologists, Family Physicians
  
  
  OBJECTIVE
  After completion of this article, the reader will be able to describe the condition idiopathic juvenile osteoporosis, compare the clinical features of this condition to other similar conditions, outline the diagnostic workup of a child with this condition, and list the potential therapeutic options for a patient with idiopathic juvenile osteoporosis.
authors.affiliation: Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center, Amarillo, 79106, USA. robertk@ama.tthusc.edu
authors.forename: R P
authors.initials: RP
authors.lastname: Kauffman
authors.forename: T H
authors.initials: TH
authors.lastname: Overton
authors.forename: M
authors.initials: M
authors.lastname: Shiflett
authors.forename: J C
authors.initials: JC
authors.lastname: Jennings
mesh_terms: D000293:Adolescent; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002136:Calcium, Dietary / Q000008:administration & dosage; D003937:Diagnosis, Differential; D012968:Etidronic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000175:diagnosis* / Q000188:drug therapy; D000068296:Risedronic Acid; D014807:Vitamin D / Q000627:therapeutic use
chemical_list: D002121:Calcium Channel Blockers; D002136:Calcium, Dietary; D014807:Vitamin D; D000068296:Risedronic Acid; D012968:Etidronic Acid